Visus CEO updates on lead product candidate, 2021 pipeline

Visus Therapeutics CEO Ben Bergo shares an update on the status of its lead product candidate for presbyopia treatment as well as what's in the company's pipeline for 2021.

Related Videos

Related Content

Advertisement

November 1st 2024

AAO 2024: Ocular imaging in the emergency department can provide timely, accurate diagnosis

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

October 22nd 2024

Life Biosciences reports advances in nonhuman primate studies on partial epigenetic reprogramming for restoring visual function

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

October 20th 2024

AAO 2024: 3D printed eyeglasses bring vision care to children in underserved, remote communities

October 20th 2024

AAO 2024: LiGHT trial shows SLT outperforms medications in reducing glaucoma progression over 6 years

Related Content

Advertisement

November 1st 2024

AAO 2024: Ocular imaging in the emergency department can provide timely, accurate diagnosis

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

October 22nd 2024

Life Biosciences reports advances in nonhuman primate studies on partial epigenetic reprogramming for restoring visual function

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

October 20th 2024

AAO 2024: 3D printed eyeglasses bring vision care to children in underserved, remote communities

October 20th 2024

AAO 2024: LiGHT trial shows SLT outperforms medications in reducing glaucoma progression over 6 years